How closely related is graft-vs-leukemia to donor/recipient disparity?

被引：6

作者：

Weisdorf, Daniel J. ^{[1
]}

机构：

[1] Univ Minnesota, Minneapolis, MN 55455 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2010年 / 23卷 / 04期

关键词：

graft-vs-leukemia effect; GVL; graft-vs-host disease; GVHD; acute leukemia; human leukocyte antigen; HLA; mismatch; unrelated donor; cord blood; conditioning regimen; VERSUS-HOST-DISEASE; CELL TRANSPLANTATION; SEVERITY; RELAPSE; DONORS;

D O I：

10.1016/j.beha.2010.09.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Graft-vs-host disease (GVHD) is an unwanted complication of stem cell transplant, but the graft-vs-leukemia (GVL) effect has been shown to positively affect outcomes. GVHD and GVL have similar but not identical alloreactivity, and GVL may be affected by the source of grafts, the preparative conditioning regimen, and donor genetic elements. Human leukocyte antigen (HLA) mismatch does not appear to augment the GVL effect, and increased GVHD does not necessarily lead to decreased relapse. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：525 / 528

页数：4

共 50 条

[21] DISSOCIATING GRAFT-VS-HOST DISEASE FROM THE GRAFT-VS-LEUKEMIA EFFECT OF ALLOGENEIC T-CELLS - THE POTENTIAL ROLE OF IL-2
SYKES, M
BONE MARROW TRANSPLANTATION, 1992, 10 : 1 - 4
[22] Graft-Vs-Leukemia Effect in Acute Lymphoblastic Leukemia: Mild Acute Graft-Vs-Host Disease Protects Against Relapse and Improves Survival after Allogeneic Transplantation: A CIBMTR Analysis
Yeshurun, Moshe
Weisdorf, Daniel J.
Zhang, Mei-Jie
Wang, Hai-Lin
Flowers, Mary E.
De Lima, Marcos
Rowe, Jacob M.
Sandmaier, Brenda M.
Tallman, Martin S.
Verneris, Michael R.
Bachanova, Veronika
BLOOD, 2017, 130
[23] Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia
Cho, Byung-Sik
Jeon, Young-Woo
Hahn, A-Reum
Lee, Tai-Hyang
Park, Sung-Soo
Yoon, Jae-Ho
Lee, Sung-Eun
Eom, Ki-Seong
Kim, Yoo-Jin
Lee, Seok
Min, Chang-Ki
Cho, Seok-Goo
Lee, Jong-Wook
Min, Woo-Sung
Kim, Hee-Je
CANCER MEDICINE, 2019, 8 (02): : 501 - 514
[24] THE GRAFT-VS-LEUKEMIA (GVL) EFFECT OF DONOR MONONUCLEAR CELL (MNC) INFUSIONS FOR PATIENTS WITH RELAPSED ACUTE-LEUKEMIA AND MYELODYSPLASIA (MDS) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
PORTER, D
ROTH, M
MCGARIGLE, C
LEE, S
FERRARA, J
ANTIN, J
BLOOD, 1994, 84 (10) : A338 - A338
[25] Human monocyte-derived suppressor cells control graft-vs-host disease while preserving graft-vs-leukemia effect and acquire clinically relevant qualities
Janikashvili, N.
Samson, M.
Thebault, M.
Brazdova, A.
Berulava, T.
Ciudad, M.
Audia, S.
Bonnotte, B.
ALLERGY, 2016, 71 : 165 - 165
[26] CHARACTERIZATION OF ALLOIMMUNIZATION-INDUCED LYMPHOCYTES-T REACTIVE AGAINST AKR LEUKEMIA INVITRO AND CORRELATION WITH GRAFT-VS-LEUKEMIA ACTIVITY INVIVO
TRUITT, RL
SHIH, CY
LEFEVER, AV
TEMPELIS, LD
ANDREANI, M
BORTIN, MM
JOURNAL OF IMMUNOLOGY, 1983, 131 (04): : 2050 - 2058
[27] THE ROLE OF LYMPHOKINE ACTIVATED KILLER CELLS AS GRAFT-VS-LEUKEMIA EFFECTORS AFTER T-CELL DEPLETED BMT
HAUCH, M
BORDIGNON, C
CUNNINGHAM, I
BROCHSTEIN, J
OREILLY, RJ
KEEVER, CA
IMMUNOBIOLOGY, 1988, 178 (1-2) : 78 - 78
[28] Does Donor/Recipient Ethnic Disparity Affect Graft Survival in Hepatitis C Positive Renal Allograft Recipients?
Yalamanchili, Venkata
Goggins, Mariella
Patel, Anita
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 331 - 331
[29] Engraftment of allogeneic (ALLO) stem cells with purine analog containing non-myeloablative regimens for induction of graft-vs-leukemia
Giralt, S
Estey, E
vanBesien, K
Gajewski, J
Koller, C
Albitar, M
Korbling, M
Champlin, R
EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 125 - 125
[30] Whole liver vs. cadaver split liver vs living donor in the adult recipient - Is it donor source or graft type that matters more?
Humar, A
Carolan, E
Kalis, A
Nelson, S
Gruessner, A
Lake, J
Payne, W
LIVER TRANSPLANTATION, 2005, 11 (07) : C31 - C31

← 1 2 3 4 5 →